Back to catalogue
№ 415 17 filings · 2021-11-02 → 2026-07-30

TRIAD GROUP PLC

TRD
Technology Share price 390p Market cap £68m Overall fit 210 /1000

Poor fit for the strategy: not an AI beneficiary (T&M consultancy is arguably an AI substitution victim), weak operating leverage on a variable people-cost base, and the shares trade at ~39x earnings — the opposite of valuation discipline. Downside-protection is a genuine plus (net cash, dividend, no debt) but insufficient to offset the other three failed pillars.

Fair value range 150p–220p Mid case · £32m
Absolute upside -52.7% vs current market cap
Conviction 3/5 confidence in overvalued call
Supports the call
  • clean audited financials with 5-year history
  • net cash balance sheet — unambiguous
  • two valuation methods converge on 150-220p
Limits the call
  • market may keep paying AI/recovery narrative multiple for longer than fundamentals justify
  • strategic-acquirer takeout premium not modelled
Methodology

Peer P/E (12-18x) + EV/EBITDA (10-14x) cross-check

In one line · bull case

Genuine operational recovery in a debt-free niche UK public-sector consultancy — but the stock is priced as if it were a software business, not a body-shop.

In one line · biggest risk

96% public-sector revenue concentration means a UK spending review or single-programme cancellation cascades directly through the P&L, while AI tooling may structurally compress addressable demand for the mid-tier consulting work Triad delivers.

Drivers
AI beneficiary 25 /100
Deploys AI internally (Copilot, coding assistants) but has no AI-driven revenue line; commodity T&M consulting is arguably on the wrong side of AI substitution.
Operating leverage 25 /100
People-cost base scales with revenue; gross margin actually contracted in FY26 despite 16% revenue growth. Only central overheads (~£4.8m) provide any leverage.
Earnings vs expectations 55 /100
Recovery pattern from FY24 loss to FY26 beat — but track record is choppy; insufficient formal guidance/consensus disclosure to score decisively.
Growth momentum 65 /100
Revenue +16% FY26, headcount +23%, forward contract book secured through Met Office and OPSS wins — genuine positive momentum.
Moat 30 /100
Framework positions (TS4, DOS7, G-Cloud) and long-tenured client relationships create some stickiness; nothing structural.
Earnings quality 70 /100
Clean cash-converting earnings, £2.3m operating cash inflow vs £1.9m PBT; deferred tax movements add some noise but are well-explained.
Management quality 45 /100
Long tenure and continuity are positives, but non-compliance with seven Corporate Governance Code provisions and 42% dissent at last AGM are red flags.
Cyclicality 45 /100
Public-sector IT spend is only moderately cyclical but is fully exposed to UK government spending reviews and political change.
Leverage 5 /100
Fortress balance sheet — £4.2m net cash, no external debt, only IFRS 16 lease liability of £0.35m.
Value-trap signals · 5
  • Related-party lease with JC Rigg (£215k annual rent, 50% beneficial interest)
  • 42% AGM dissent on FY25 accounts, two special resolutions failed
  • Corporate governance code non-compliance across seven provisions
  • Extreme customer concentration (top client 22%, public sector 96%)
  • Auditor rotation FY26 (BDO 20-year tenure ended)

Triad Group Plc (TRD) — Investment Research Note

Executive summary

Triad is a small-cap UK IT consultancy providing digital transformation, business analysis and software delivery services almost exclusively to the UK public sector on a time-and-materials basis. Across the period the business has staged a strong operational recovery — revenue rose from £14.0m in FY24 to £24.8m in FY26, PBT swung from a £1.3m loss to £1.9m profit, and headcount grew from ~117 to 180 FTEs — driven by material contract wins at DESNZ, OPSS, Met Office and FCDO. The single most important valuation point today is that the shares have re-rated aggressively (up ~85% in the last 12 months) on scale-recovery + AI narrative, but at 385p the stock is trading at ~39x trailing earnings for a low-margin, capital-light body-shop with 96% public-sector exposure — pricing that leaves no margin of safety.

Fair value estimate

  • Methodology: primary — forward P/E on normalised earnings; cross-check — EV/EBITDA multiple applied to trailing FY26 numbers.
  • Key assumptions:
    • Sustainable EPS of 10–11p (FY26 delivered 9.92p; FY27 modest growth given contract book).
    • Peer P/E range 12–18x for small-cap UK IT services (Made Tech, RCDO, Kin+Carta-type profile pre-take-private, with premium for net cash / no restatement history).
    • EV/EBITDA: 10–14x on £2.0m EBITDA + £4.2m net cash → £24m–£32m EV, £28m–£36m equity value.
  • Fair value range: 150p – 220p per share, implying market cap of £26m – £38m (mid £32m at ~185p).
  • Latest disclosed market cap £67.1m vs. mid fair value £32m.
  • Absolute downside: ~-52% (share price would need to fall from 385p to ~185p to reach mid fair value).

Sector context

  • ICB Technology — IT services / digital consultancy is the correct sub-classification.
  • Quality is in line with sector peers on balance-sheet strength (net cash, no debt), but below typical peers on scale, customer diversification (top client 22% of revenue), and margins (gross ~27%, EBITDA margin ~8%).
  • Comparable UK-listed peers: Made Tech (MTEC) — closest peer, also public-sector digital delivery; Sopra Steria — larger scale, similar client mix; Kin+Carta (pre-take-private) — digital consultancy comparator.

Investment thesis (three bullets)

  1. Public-sector contract book is genuinely improving. Nearly £20m of contract wins at Met Office, OPSS, plus new logos at MHRA and FCDO extensions provide two years of forward-secured revenue 2026-06 final results. This is a real operational inflection, not just narrative.
  2. Fortress balance sheet with rising dividends. Zero debt, £4.2m cash, 9p total dividend for FY26 (up 50% YoY), 30-year listed track record and no bad-debt exposure through Covid or the FY24 slump 2026-06 final results; 2025-06 final results. Downside protection is real.
  3. Head-count leverage on flat back-office. Fee-earner:admin ratio moved from 23:1 to 31:1 as growth accelerated; management explicitly targets adding delivery consultants without growing the central cost base 2026-06 final results.

Key risks (three bullets)

  1. Extreme public-sector concentration. Public sector = 96% of FY26 revenue; single largest client = 22%; four clients >10% each 2026-06 final results. Any UK spending review or programme cancellation cascades directly through the P&L.
  2. Governance and related-party issues. Executive Chairman also runs the audit role, no independent CEO, Rigg family controls ~29% of shares, 50% beneficial interest in the leased office (annual rent £215k), 42% of shares voted against the accounts at the 2025 AGM 2025-07 AGM results; 2026-06 final results, note 22. Not "not disclosed" — actively disclosed and material.
  3. T&M consultancy is structurally exposed to AI substitution risk, not benefiting from AI spend. Cost base is 100% people; AI coding tools and agentic implementation platforms plausibly compress the addressable market for junior/mid-tier BA and delivery consultants over the next 3–5 years — management explicitly frames AI as an "opportunity" but has no AI-driven revenue line to point to 2026-06 final results, R&D section.

Operating leverage

Operating leverage here is weak-to-moderate at best. The cost base is dominated by staff costs (£16.6m of £22.9m total costs, 72% of revenue) and staff costs scale directly with revenue, since gross margin is a function of consultant utilisation, not fixed-cost absorption. The Chairman explicitly acknowledges this in the FY26 strategic report: "Growth in the fee earning permanent consultant headcount in-line with contract wins results in an increasingly larger fixed cost base that must be matched by revenue" 2026-06 final results. Gross margin actually contracted from 28.6% to 27.1% despite 16% revenue growth (offset by NI increases and salary inflation). The genuine leverage is central admin (£4.8m and only up £0.1m on £3.4m revenue increase), so a 10-20% revenue beat would drive perhaps 20-30% EBIT uplift — not a "multiple of profit" outcome. This is a services scaling model, not a software or platform model.

Value-trap signals

  • Related-party lease — director JC Rigg has 50% beneficial interest in an office rent-fixed since 2008 at £215k/year.
  • Governance non-compliance across seven UK Corporate Governance Code provisions (no separate CEO, no nominations committee, chair on audit committee, chair beyond 9-year tenure, informal Board evaluation).
  • Recent auditor rotation (BDO's 20-year tenure ended FY26; HaysMac appointed). Handovers can obscure period-to-period comparability.
  • AGM voting friction — 42% of votes cast against the FY25 accounts and remuneration report; two special resolutions failed to pass. Reflects a large dissenting shareholder bloc.
  • Very small floating share base and one shareholder (M Makar) at 19.95% — illiquidity risk in a downdraft.

Earnings vs. expectations

The filings do not disclose formal quarterly guidance or analyst consensus (typical for a nano-cap). Directional read: the FY24 result was a material earnings collapse (revenue down 5%, £1.3m PBT loss) after a strong FY22. The recovery arc in FY25 and FY26 has been an upside surprise vs. the depressed FY24 base, and the trading updates (Aug 2024, Mar 2024, Jan 2023) shifted from cautious/apologetic (delays outside our control) to optimistic. Pattern: choppy delivery — one significant miss (FY24), followed by two years of solid beats vs. a low bar. Not enough consistent guidance data to score with confidence.

Conviction

Conviction: 3 (moderate)

Anchors: (a) financials are clean, cash-based, and consistently disclosed over a 5-year window; (b) balance sheet is unambiguous (net cash, no debt, no goodwill); (c) two independent methodologies (P/E and EV/EBITDA) converge on the same ~150–220p range.

Limits: (a) the current multiple is being driven by narrative (recovery + AI-halo) rather than a clean earnings anchor, so the market clearing price could persist above fundamentals for a while; (b) a strategic acquirer could pay a premium for the frameworks-and-relationships, which is not captured in the DCF-style approach.

Filings consulted · 23

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-30Result OF Agm2026-07-30_9696340_result-of-agm.md0.30
  2. 2026-07-07Notice OF Agm And Dividend Declaration2026-07-07_9656691_notice-of-agm-and-dividend-declaration.md0.30
  3. 2026-06-22Final Results2026-06-22_9628616_final-results.md1.00
  4. 2025-11-25Half Year Financial Report2025-11-25_9254491_half-year-financial-report.md0.77
  5. 2025-07-30Result OF Agm2025-07-30_9012718_result-of-agm.md0.20
  6. 2025-07-07Notice OF Agm And Dividend Declaration2025-07-07_8967269_notice-of-agm-and-dividend-declaration.md0.20
  7. 2025-06-16Final Results2025-06-16_8929970_final-results.md0.65
  8. 2024-11-07Half Year Report2024-11-07_8534634_half-year-report.md0.58
  9. 2024-08-23Result OF Agm2024-08-23_8382824_result-of-agm.md0.14
  10. 2024-08-22Trading Statement2024-08-22_8380262_trading-statement.md0.38
  11. 2024-07-31Notice OF Agm2024-07-31_8341739_notice-of-agm.md0.14
  12. 2024-03-07Trading Statement2024-03-07_8076473_trading-statement.md0.38
  13. 2023-12-20Half Year Report2023-12-20_7952603_half-year-report.md0.41
  14. 2023-07-27Result OF Agm2023-07-27_7659418_result-of-agm.md0.07
  15. 2023-07-04Notice OF Agm2023-07-04_7612601_notice-of-agm.md0.07
  16. 2023-07-04Dividend Declaration2023-07-04_7612599_dividend-declaration.md0.07
  17. 2023-07-04Correction Dividend Declaration2023-07-04_7612867_correction-dividend-declaration.md0.07
  18. 2023-01-18Trading Statement2023-01-18_7442765_trading-statement.md0.21
  19. 2022-12-01Half Year Report2022-12-01_7264804_half-year-report.md0.23
  20. 2022-07-21Result OF Agm2022-07-21_7083606_result-of-agm.md0.07
  21. 2022-06-28Notice OF Agm2022-06-28_7115277_notice-of-agm.md0.07
  22. 2022-06-28Dividend Declaration2022-06-28_7115248_dividend-declaration.md0.07
  23. 2021-11-02Half Year Report2021-11-02_6626396_half-year-report.md0.23

This research note was authored by a large language model after reading 17 regulatory filings published between 2021-11-02 and 2026-07-30. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.